ZHAO, Z. et al. 2020. Cardiovascular and safety events of PCSK9 inhibitors in statin-treated patients with cardiovascular risk: A Systematic Review and Meta-Analysis. Journal of Pharmacy & Pharmaceutical Sciences. 23, (Oct. 2020), 422–436. DOI:https://doi.org/10.18433/jpps31197.